Bevacizumab biosimilar
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Bevacizumab biosimilar, covering 2021-04-14 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03) [Phase 2]